Cell Biochemistry and Biophysics, Journal Year: 2024, Volume and Issue: unknown
Published: Nov. 13, 2024
Language: Английский
Cell Biochemistry and Biophysics, Journal Year: 2024, Volume and Issue: unknown
Published: Nov. 13, 2024
Language: Английский
Biomedicine & Pharmacotherapy, Journal Year: 2025, Volume and Issue: 183, P. 117818 - 117818
Published: Jan. 17, 2025
Language: Английский
Citations
1Phytomedicine Plus, Journal Year: 2025, Volume and Issue: unknown, P. 100744 - 100744
Published: Jan. 1, 2025
Language: Английский
Citations
1Heliyon, Journal Year: 2024, Volume and Issue: 10(13), P. e32755 - e32755
Published: June 8, 2024
The involvement of neuroinflammation in the pathogenesis neurodegenerative disorders (NDs) is very significant. Currently, only symptomatic treatments exist, and there are no drugs that modify progression Alzheimer's disease (AD) or other NDs. Consequently, increasing attention on addressing AD-related using anti-inflammatory compounds antioxidants. a growing exploration dietary phytochemicals as potential therapeutic agents for treating inflammation. Citral, monoterpene, under investigation due to its neuroprotective effects. dysregulation iron homeostasis crucial factor supporting neuroinflammation, underscoring significance proper balance. Human transferrin (htf) major homeostasis. In this study, we examined binding dynamics htf–citral complex through diverse experimental methods. Molecular docking studies revealed citral binds residues htf, forming stable complex. UV-visible spectroscopy demonstrated with htf good affinity, evident from constant 1.48 X105 M-1. Further, fluorescence entrenched htf-citral formation; demonstrates an excellent affinity 106 Moreover, assay at various temperatures deciphered be driven by both static dynamic quenching. analysis enthalpy change (ΔH) entropy (ΔS) formation was mainly hydrophobic interactions..The current work gives platform develop innovative strategies targeting citral, particularly
Language: Английский
Citations
5Brain Injury, Journal Year: 2025, Volume and Issue: unknown, P. 1 - 17
Published: April 21, 2025
TBI's intricate pathophysiology, which includes oxidative stress, neuroinflammation, apoptosis, and mechanical injury, makes it a serious public health concern. Although stabilization secondary damage management are the main goals of current treatments, their efficacy is still restricted. The potential for improving patient outcomes by combining phytochemicals with traditional medicines examined in this review. study neuroprotective qualities ginsenosides, ginkgolides, resveratrol, curcumin as well antioxidant anti-inflammatory activities. Analysis was done on molecular pathways medication delivery techniques to improve translational drug availability clinical practice. Phytochemical substances directly influence TBI-related neurogenic functional restoration while also affecting subsequent neural processes. Particle-based medicine platforms enhance therapeutic efficacy, emerging innovative solutions targeted delivery. When medical therapies integrate phytochemicals, becomes possible achieve better results through enhanced synergy. This review uniquely integrates standard TBI emphasizing advanced strategies neuroprotection outcomes. Unlike previous studies, explores novel platforms, such nanoparticle-based systems, highlights synergy between conventional recovery.
Language: Английский
Citations
0Pharmacological Research - Natural Products, Journal Year: 2025, Volume and Issue: 7, P. 100249 - 100249
Published: May 5, 2025
Language: Английский
Citations
0Ageing Research Reviews, Journal Year: 2024, Volume and Issue: 100, P. 102469 - 102469
Published: Aug. 25, 2024
Language: Английский
Citations
3Cell Biochemistry and Biophysics, Journal Year: 2024, Volume and Issue: unknown
Published: Nov. 13, 2024
Language: Английский
Citations
2